Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
1992 | 2 |
2008 | 1 |
2012 | 1 |
2013 | 2 |
2015 | 1 |
2016 | 2 |
2017 | 1 |
2024 | 0 |
Search Results
7 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
An update on the role of ploidy in prostate carcinoma.
Henry Ford Hosp Med J. 1992;40(1-2):99-102.
Henry Ford Hosp Med J. 1992.
PMID: 1428988
Free article.
Review.
Efficacy and safety of oxybutynin topical gel 3% in patients with urgency and/or mixed urinary incontinence: a randomized, double-blind, placebo-controlled study.
Goldfischer ER, Sand PK, Thomas H, Peters-Gee J.
Goldfischer ER, et al. Among authors: peters gee j.
Neurourol Urodyn. 2015 Jan;34(1):37-43. doi: 10.1002/nau.22504. Epub 2013 Oct 16.
Neurourol Urodyn. 2015.
PMID: 24133005
Clinical Trial.
Item in Clipboard
Tolterodine extended release is efficacious in continent and incontinent subjects with overactive bladder.
Rovner ES, Rackley R, Nitti VW, Wang JT, Guan Z; 037 Study Group.
Rovner ES, et al.
Urology. 2008 Sep;72(3):488-93. doi: 10.1016/j.urology.2008.05.019. Epub 2008 Jul 17.
Urology. 2008.
PMID: 18639327
Clinical Trial.
Item in Clipboard
OnabotulinumtoxinA for the treatment of patients with overactive bladder and urinary incontinence: results of a phase 3, randomized, placebo controlled trial.
Nitti VW, Dmochowski R, Herschorn S, Sand P, Thompson C, Nardo C, Yan X, Haag-Molkenteller C; EMBARK Study Group.
Nitti VW, et al.
J Urol. 2013 Jun;189(6):2186-93. doi: 10.1016/j.juro.2012.12.022. Epub 2012 Dec 14.
J Urol. 2013.
PMID: 23246476
Clinical Trial.
Item in Clipboard
Durable Efficacy and Safety of Long-Term OnabotulinumtoxinA Treatment in Patients with Overactive Bladder Syndrome: Final Results of a 3.5-Year Study.
Nitti VW, Ginsberg D, Sievert KD, Sussman D, Radomski S, Sand P, De Ridder D, Jenkins B, Magyar A, Chapple C; 191622-096 Investigators.
Nitti VW, et al.
J Urol. 2016 Sep;196(3):791-800. doi: 10.1016/j.juro.2016.03.146. Epub 2016 Mar 30.
J Urol. 2016.
PMID: 27038769
Clinical Trial.
Item in Clipboard
Prognostic significance of DNA quantitation in stage D1 prostate carcinoma with the use of image analysis.
Peters-Gee JM, Miles BJ, Cerny JC, Gaba AR, Jacobsen G, Crissman JD.
Peters-Gee JM, et al.
Cancer. 1992 Sep 1;70(5):1159-65. doi: 10.1002/1097-0142(19920901)70:5<1159::aid-cncr2820700522>3.0.co;2-l.
Cancer. 1992.
PMID: 1515991
Item in Clipboard
OnabotulinumtoxinA for the Treatment of Patients with Overactive Bladder and Urinary Incontinence: Results of a Phase 3, Randomized, Placebo Controlled Trial.
Nitti VW, Dmochowski R, Herschorn S, Sand P, Thompson C, Nardo C, Yan X, Haag-Molkenteller C; EMBARK Study Group.
Nitti VW, et al.
J Urol. 2017 Feb;197(2S):S216-S223. doi: 10.1016/j.juro.2016.10.109. Epub 2016 Dec 22.
J Urol. 2017.
PMID: 28012773
Clinical Trial.
Item in Clipboard
Cite
Cite